SAN DIEGO–(BUSINESS WIRE)—- $GUTS #Fractyl–Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 (the “Class Period”). Fractyl is a metabolic therapeutics company that develops therapies for the treatment of type 2 diabetes (“T2D”) and obesity. The complaint alleges that Fractyl Health misled investors regarding